Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?

Prescriptions for Benzodiazepines (BZDs) have risen continually. According to national statistics, the combination of BZDs with opioids has increased since 1999. BZDs (sometimes called “benzos”) work to calm or sedate a person by raising the level of the inhibitory neurotransmitter GABA in the brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, K, Gold, M, Modestino, EJ, Baron, D, Boyett, B, Siwicki, D, Lott, L, Podesta, A, Roy, AK, Hauser, M, Downs, BW, Badgaiyan, RD
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865059/
https://www.ncbi.nlm.nih.gov/pubmed/31750006
http://dx.doi.org/10.15761/JSIN.1000196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6865059/
https://www.ncbi.nlm.nih.gov/pubmed/31750006
http://dx.doi.org/10.15761/JSIN.1000196

Ejemplares similares